Daxor Long Term Debt 2010-2011 | DXR

Daxor long term debt from 2010 to 2011. Long term debt can be defined as the sum of all long term debt fields.
Daxor Annual Long Term Debt
(Millions of US $)
2011 $
2010 $
2009 $
Daxor Quarterly Long Term Debt
(Millions of US $)
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.038B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.525B 11.81
Quest Diagnostics (DGX) United States $17.124B 17.35
DaVita (DVA) United States $12.715B 16.44
Encompass Health (EHC) United States $9.488B 22.37
Chemed (CHE) United States $7.824B 24.05
Elanco Animal Health (ELAN) United States $5.873B 13.98
RadNet (RDNT) United States $5.431B 120.26
Option Care Health (OPCH) United States $3.882B 18.40
LifeStance Health (LFST) United States $2.789B 0.00
Amedisys (AMED) United States $2.789B 19.85
Addus HomeCare (ADUS) United States $2.337B 27.42
Astrana Health (ASTH) United States $1.883B 25.75
U.S Physical Therapy (USPH) United States $1.362B 35.82
Pennant (PNTG) United States $0.925B 37.42
Aveanna Healthcare Holdings (AVAH) United States $0.854B 0.00
Atai Life Sciences (ATAI) Germany $0.206B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.006B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00